WFDC1 Antibody (C-term H163) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9HC57 |
---|---|
Clone Names | 80924278 |
Gene ID | 58189 |
---|---|
Other Names | WAP four-disulfide core domain protein 1, Prostate stromal protein ps20, ps20 growth inhibitor, WFDC1, PS20 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | WFDC1 |
---|---|
Synonyms | PS20 |
Function | Has growth inhibitory activity. |
Cellular Location | Secreted. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes a member of the WAP-type four disulfidecore domain family. The WAP-type four-disulfide core domain, or WAPsignature motif, contains eight cysteines forming four disulfidebonds at the core of the protein, and functions as a proteaseinhibitor in many family members. The encoded protein shares 81%amino acid identity with the rat ps20 protein, which was originallyidentified as a secreted growth inhibitor. This gene is mapped tochromosome 16q24, an area of frequent loss of heterozygosity incancers, including prostate, breast and hepatocellular cancers andWilms' tumor. Owing to its location and a possible growthinhibitory property of its gene product, this gene is suggested tobe a tumor suppressor gene.
References
Briggs, F.B., et al. Genes Immun. 11(3):199-208(2010)Madar, S., et al. Carcinogenesis 30(1):20-27(2009)Liu, S., et al. Clin. Exp. Metastasis 26(7):739-749(2009)Alvarez, R., et al. J. Virol. 82(1):471-486(2008)Watson, J.E., et al. Prostate 61(2):192-199(2004)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.